Ibrance (chemical name: palbociclib) is used in combination with a type of hormonal therapy called an aromatase inhibitor to treat advanced-stage or metastatic, hormone-receptor-positive, HER2-negative breast cancer that hasn’t been treated with hormonal therapy before in postmenopausal women or men.
Palbociclib
$2,982.00 – $11,172.00
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.